11/20
08:36 am
prfx
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial [Yahoo! Finance]
Medium
Report
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial [Yahoo! Finance]
11/20
08:30 am
prfx
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
Low
Report
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
11/7
05:07 pm
prfx
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement [Yahoo! Finance]
Low
Report
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement [Yahoo! Finance]
11/7
05:00 pm
prfx
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
Low
Report
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
10/25
09:26 am
prfx
PainReform cut to Hold at Maxim amid ‘changed' market dynamics [Yahoo! Finance]
Medium
Report
PainReform cut to Hold at Maxim amid ‘changed' market dynamics [Yahoo! Finance]
10/24
10:10 am
prfx
PainReform Ltd. (NASDAQ: PRFX) had its "hold" rating re-affirmed by analysts at Maxim Group.
Medium
Report
PainReform Ltd. (NASDAQ: PRFX) had its "hold" rating re-affirmed by analysts at Maxim Group.
9/11
08:30 am
prfx
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
High
Report
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
9/10
09:46 am
prfx
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
High
Report
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds